Publication | Open Access
Effectiveness of three calcitonin gene-related peptide monoclonal antibodies for migraine: A 12-month, single-center, observational real-world study in Japan
46
Citations
33
References
2023
Year
This real-world study confirmed the efficacy and safety of three different CGRP mAbs for prophylactic treatment of patients with migraine.
| Year | Citations | |
|---|---|---|
Page 1
Page 1